none6The evaluation variables influencing systemic and local recurrence and final outcome are extremely important in defining risk-adapted treatments for patients with nonmetastatic osteosarcoma of the extremity. METHODS: A homogeneous group of 789 patients treated at a single institution between March 1983 and March 1999 with different protocols of neoadjuvant chemotherapy, with a minimum followup of 5 years, were retrospectively evaluated in relation to gender, age, serum levels of alkaline phosphatase, tumor site and size of the pathologic fracture, type of surgery, protocol of chemotherapy, surgical margins, and histologic response to preoperative treatment. RESULTS: The 5-year event-free survival (EFS) and overall survival rates were 6...
From January 1993 to March 1995, 162 patients with osteosarcoma of extremities were treated accordin...
Aim: Finding reliable prognostic factors for osteosarcoma remains problematic. A systematic review [...
BACKGROUND. In primary central high-grade osteosarcoma, a number of distinct subtypes have been iden...
The evaluation variables influencing systemic and local recurrence and final outcome are extremely i...
To determine the prognostic factors that influence survival of patients with non-metastatic, high-gr...
none6Around 1148 patients with non-metastatic osteosarcoma of the extremity were treated in a single...
Background: To identify predictive factors of disease-free sur-vival (DFS) in patients with non-meta...
INTRODUCTION: Identification of variables that determine the prognosis for osteosarcoma may enable s...
To retrospectively review the effect of chemotherapy and survival rate of osteosarcoma in extremity....
Background: Effective adjuvant or neoadjuvant regimens of chemotherapy have dramatically improved th...
Purpose: The aim of this study was to compare the results in terms of histologic response to primary...
Between September 1986 and December 1988, 125 patients with osteosarcoma of the extremities entered ...
PURPOSE: The aim of this study was to compare the results in terms of histologic response to prim...
Background.Multimodality treatment, incorporating neoadjuvant chemotherapy and adjuvant chemotherapy...
From January 1993 to March 1995, 162 patients with osteosarcoma of extremities were treated accordin...
Aim: Finding reliable prognostic factors for osteosarcoma remains problematic. A systematic review [...
BACKGROUND. In primary central high-grade osteosarcoma, a number of distinct subtypes have been iden...
The evaluation variables influencing systemic and local recurrence and final outcome are extremely i...
To determine the prognostic factors that influence survival of patients with non-metastatic, high-gr...
none6Around 1148 patients with non-metastatic osteosarcoma of the extremity were treated in a single...
Background: To identify predictive factors of disease-free sur-vival (DFS) in patients with non-meta...
INTRODUCTION: Identification of variables that determine the prognosis for osteosarcoma may enable s...
To retrospectively review the effect of chemotherapy and survival rate of osteosarcoma in extremity....
Background: Effective adjuvant or neoadjuvant regimens of chemotherapy have dramatically improved th...
Purpose: The aim of this study was to compare the results in terms of histologic response to primary...
Between September 1986 and December 1988, 125 patients with osteosarcoma of the extremities entered ...
PURPOSE: The aim of this study was to compare the results in terms of histologic response to prim...
Background.Multimodality treatment, incorporating neoadjuvant chemotherapy and adjuvant chemotherapy...
From January 1993 to March 1995, 162 patients with osteosarcoma of extremities were treated accordin...
Aim: Finding reliable prognostic factors for osteosarcoma remains problematic. A systematic review [...
BACKGROUND. In primary central high-grade osteosarcoma, a number of distinct subtypes have been iden...